IFNG and acute myeloid leukemia: We have recently used the NanoString immune gene expression profiling platform to decipher the complexity of the AML BM microenvironment and to identify molecular determinants of AML sensitivity to IFN-γ, patient response to chemotherapy and patient survival [83,84].